No difference was observed in the number of CD8+ lymphocytes among tumours with different SSTR2 expression [score 0–1 median CD8+ lymphocytes 0.2/HPF (IQR: 1.4), score 2 median 1.4/HPF (IQR: 1.6) and score 3 median 1.7/HPF (IQR: 2.4); P = 0.26]. Here, SSTR2 is linked to neoplasm.